COVID-19 news from experts at Columbia University Irving Medical Center. Visit our Coronavirus Resource Center for the latest COVID-19 information for CUIMC providers, staff, students, researchers and patients.
Search All News
The latest omicron subvariants—especially the currently dominant BA.4 and BA.5 forms—are even better at eluding vaccines and most treatments, find researchers at Columbia University.
Community outreach and restricting online scheduling to certain zip codes helped increase vaccine uptake among Black and Hispanic residents, new study says.
Columbia scientists have joined a regional consortium to accelerate the development of new drugs that target SARS-CoV-2, other coronaviruses, and viruses that could lead to future pandemics.
In the wake of the COVID pandemic, Anne Moscona is bringing an appreciation for public outreach to her upcoming role as president of the American Society for Virology.
- February 26, 2021
People who took statins to lower cholesterol were about 50% less likely to die if hospitalized for COVID-19, a retrospective study by Columbia University and NewYork-Presbyterian physicians has found.
- February 25, 2021
Spread of a new SARS-CoV-2 variant in the New York City region that shares worrisome similarities with other recent variants has been identified by scientists at Columbia University.
- February 17, 2021
A nasal spray created by Columbia researchers prevented transmission of SARS-CoV-2 in ferrets, suggesting the spray could also prevent transmission of the coronavirus in people.
- February 15, 2021
Columbia faculty and staff speak about their experiences while volunteering at the Armory vaccination site.
- February 12, 2021
Years before COVID-19, Columbia began laying the groundwork for this month’s symposium on vaccines and pandemic preparedness.
- February 5, 2021
Pregnant women face greater risks to their health from COVID-19 than the general population and should be offered a vaccine if eligible, say experts at Columbia and NewYork-Presbyterian.
- February 5, 2021
Cancer patients on active treatment are 35% less likely to develop COVID-19 than patients not receiving treatment, though those who did test positive for SARS-CoV-2 experienced higher death rates.
- January 26, 2021
Prioritizing older New Yorkers for COVID vaccines and delaying second doses could reduce hospitalizations and deaths, according to new modeling projections from Mailman epidemiologists.